JDRF Funds an Artificial Pancreas

#1

Press release from the JDRF on how they partially funded an Artificial Pancreas being developed by a South Korean company:

EOPancreas

#2

Thanks for the news, @YogaO. I was not aware of this effort. I think this is evidence that automated insulin dosing systems are adding competitors to the market, a good thing for people with diabetes.

#3

Fascinating news! What does fast track mean? A couple of years?

#4

I agree! The more the merrier! We all need choices and we all want and need different things in our diabetes tool box. Can’t wait to see how it rolls out!

#5

Fast track basically means that the FDA will try and prevent roadblocks, as they are viewing this as an innovative advancement over current treatment methods.

The press release suggests a 2021 availability.

1 Like
#6

And if all this effort and money were put towards developing an actual cure, we would not need artificial pancreas!